Brokers trade at their computer terminals at a stock brokerage firm in Mumbai. Photo: Reuters
All these three stocks were down in the range of 1%-2%, as compared to 0.16% fall in the benchmark indices at 01:21 pm.
Sun Pharma was too down 1.8% to Rs 701, also its 52-week low on NSE. The pharmaceuticals company will announce its Q2FY17 results on November 10, 2016.
The board will also consider the proposal for the merger/amalgamation of Ranbaxy Drugs Limited, Vidyut Investments Limited, Gufic Pharma Limited and Sun Pharma Medisales Private Limited (formerly known as Solrex Pharmaceutical Company), all four companies being wholly owned subsidiaries of Sun Pharmaceutical Industries, with Sun Pharmaceutical Industries subject to receipt of necessary approvals.